A single center, open-label, phase I/II study of two 90-microg doses of intramuscular inactivated influenza A/H5N1 vaccine in healthy adult subjects.

Trial Profile

A single center, open-label, phase I/II study of two 90-microg doses of intramuscular inactivated influenza A/H5N1 vaccine in healthy adult subjects.

Completed
Phase of Trial: Phase I/II

Latest Information Update: 28 Aug 2008

At a glance

  • Drugs Influenza A virus vaccine-H5N1 (Primary)
  • Indications Influenza A virus H5N1 subtype
  • Focus Pharmacodynamics
  • Most Recent Events

    • 28 Aug 2008 Actual patient number (35) added as reported by ClinicalTrials.gov.
    • 03 Jul 2008 Actual end date added (Dec 2006) as reported by ClinicalTrials.gov.
    • 03 Jul 2008 Planned number of patients has been changed from 50 to 35 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top